High fat diet differentially regulates the expression of olfactory receptors in the duodenum of obesity-prone and obesity-resistant rats

Digestive Diseases and Sciences

Volumn 58, Issue 1, 2013, Pages 72-76

  Primeaux, Stefany D ^a   Braymer, H Douglas ^b   Bray, George A ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Duodenum; High fat diet; Obesity prone; Obesity resistant; Olfactory receptors

Indexed keywords

MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT; CONTROLLED STUDY; DISEASE RESISTANCE; DOWN REGULATION; DUODENUM; FAT BODY; GENE EXPRESSION; INTESTINE CELL; LIPID DIET; MALE; MICROARRAY ANALYSIS; NONHUMAN; OBESITY; OLFACTORY RECEPTOR; PRIORITY JOURNAL; RAT; UPREGULATION; WEIGHT GAIN;

ANIMALS; DIETARY FATS; DUODENUM; ENTEROCYTES; FATTY ACIDS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; MEMBRANE PROTEINS; OBESITY; PROTEIN ARRAY ANALYSIS; RATS; RATS, INBRED STRAINS; RNA, MESSENGER;

EID: 84873190680     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2421-z     Document Type: Article

References (24)

1. Greenberg D, McCaffery J, Potack JZ, Bray GA, York DA. Differential satiating effects of fats in the small intestine of obesity-resistant and obesity-prone rats. Physiol Behav. 1999;66:621-626.
2. Liu X, York DA, Bray GA. Regulation of ghrelin gene expression in stomach and feeding response to a ghrelin analogue in two strains of rats. Peptides. 2004;25:2171-2177.
3. Pittman D, Smith KR, Crawley ME, et al. Orosensory detection of fatty acids by obesity-prone and obesity-resistant rats: strain and sex differences. Chem Sens. 2008;33:449-460.
4. Primeaux SD, Barnes MJ, Braymer HD, Bray GA. Sensitivity to the satiating effects of Exendin 4 is decreased in obesity-prone Osborne-Mendel rats compared to obesity-resistant S5B/Pl rats. Int J Obes. 2010;34:1427-1433.
5. Primeaux SD, Braymer DH, Bray GA. High fat diet differentially induces genes for fatty acid metabolism, immunity, olfaction and signal transduction in enterocytes from obesity-prone and obesity-resistant rats. Obes Rev. 2010;11:91.
6. Fleischer J, Breer H, Strotmann J. Mammalian olfactory receptors. Front Cell Neurosci. 2009;3.
7. Braun T, Voland P, Kunz L, Prinz C, Gratzl M. Enterochromaffin cells of the human gut: sensors for spices and odorants. Gastroenterology. 2007;132:1890-1901.
8. Kidd M, Modlin IM, Gustafsson BI, Drozdov I, Hauso O, Pfragner R. Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants. Am J Physiol Neuroreg Mot. 2008;295:G260-G272.
9. Joo JI, Yun JW. Gene expression profiling of adipose tissues in obesity susceptible and resistant rats under a high fat diet. Cell Physiol Biochem. 2011;27:327-340.
10. Kim DH, Choi JW, Joo JI, et al. Changes in expression of skeletal muscle proteins between obesity-prone and obesity-resistant rats induced by a high fat diet. J Proteome Res. 2011;10:1281-1292.
11. Wang X, Choi JW, Joo JI, et al. Differential expression of liver proteins between obesity-prone and obesity-resistant rats in response to high fat diet. Br J Nutr. 2011;106:612-626.
12. Primeaux SD, Blackmon C, Barnes MJ, Braymer HD, Bray GA. Central administration of the RFamide peptides, QRFP-26 and QRFP-43, increases high fat food intake in rats. Peptides. 2008;29:1994-2000.
13. Barnes MJ, Holmes G, Primeaux SD, York DA, Bray GA. Increased expression of mu opioid receptors in animals susceptible to diet-induced obesity. Peptides. 2006;27:3292-3298.
14. Primeaux SD, Barnes MJ, Bray GA. Olfactory bulbectomy increases food intake and hypothalamic neuropeptide Y in obesity-prone, but not obesity-resistant rats. Behav Brain Res. 2007;180:190-196.
15. Cirillo C, Vanden Berghe P, Tack J. Role of serotonin in gastrointestinal physiology and pathology. Minerva Endocrinol. 2011;36:311-324.
16. Gershon MD. Review article: serotonin receptors and transports-roles in normal and abnormal gastrointestinal motility. Ailment Pharmcol Ther. 2004;20:3-14.
17. Gershon MD, Liu MT. Serotonin and neuroprptoection in functional bowel disorders. Neurogastroenterol Motil. 2007;19:19-24.
18. Gorard DA, Libby GW, Farthing MJ. 5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake. Gut. 1994;35:496-500.
19. Hammer C, Kapeller J, Endele M, et al. Functional variants of the serotonin receptor type 3A and B gene associated with eating disorders. Pharmacogenet Genomics. 2009;19:790-799.
20. Machu TK. Therapeutics of 5-HT3 receptor antagonists: current uses and future directions. Pharmac Ther. 2011;130:338-347.
21. Niesler B, Kapeller J, Hammer C, Rappold G. Serotonin type 3 receptor genes: hTR3A, B, C, D, E. Pharmacogenomics. 2008;9:501-504.
22. Walstab J, Hammer C, Bonisch H, Rappold G, Niesler B. Naturally occurring variants in the HTR3B gene significantly alter properties of human heteromeric 5-hydroxytryptamine-3A/B receptors. Pharmacogenet Genomics. 2008;18:793-802.
23. White CL, Ishihara Y, York DA, Bray GA. Effect of meta- chlorophenylpiperazine and cholecystokinin on food intake of Osborne-Mendel and S5B/P1 rats. Obesity. 2007;15:624-631.
24. White CL, Kashima K, Bray GA, York DA. Effect of serotonin 1-A agonist on food intake of Osborne-Mendel and S5B/P1 rats. Physiol Behav. 2000;68:715-722.